Back to Rankings

YDES

Breeze AcquisitionN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
YDES vs peer average
50/100
YDES vs. peer average (N/A vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IKT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $224.46M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerIKTInhibikase Therapeutics
YDES
Breeze Acquisition
IKT
Inhibikase Therapeutics
Grade
N/A
B
Momentum
66
84
Value
-
41
Sentiment
-
51
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Constructive

Grade position vs IKT

YDES / IKT
Grade Position
In line
YDES vs. peer average (N/A vs. C)
50/100
Momentum
66
IKT
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs YDES
1
IKT
Inhibikase Therapeutics Inc Common
B
80/100
-
2
LENZ
LENZ Therapeutics Inc Common
D
40/100
-
3
CNTX
Context Therapeutics Inc Common
A
100/100
-
4
CRBU
Caribou Biosciences Inc Common
F
20/100
-
5
NERV
Minerva Neurosciences Inc Common
A
100/100
-
IKT is the first peer returned for this comparison set.